Milgamma Neuro (Benfotiamine, Pyridoxine Hydrochloride)

Benfotiamine and Pyridoxine Hydrochloride, the active ingredients in Milgamma Neuro, are vitamin supplements presented as an oral tablet for oral use. The formulation combines a lipid‑soluble thiamine derivative with vitamin B6 to provide synergistic metabolic support and to help maintain peripheral nerve health in adults.

GNH USA supplies Milgamma Neuro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Milgamma Neuro, containing benfotiamine and pyridoxine, is used to support peripheral nerve function and address specific vitamin deficiencies.

- Diabetic peripheral neuropathy: helps alleviate nerve discomfort associated with long‑term high blood glucose. - General peripheral neuropathy: supports nerve regeneration and reduces tingling or numbness. - Vitamin B6 deficiency: restores normal pyridoxine levels and prevents related neurological symptoms. - Metabolic support in chronic alcohol use: assists in correcting thiamine and pyridoxine deficits that can impair nerve function.

Milgamma Neuro is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea or mild stomach upset - Headache - Transient skin rash or itching - Dizziness or light‑headedness

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis, swelling of face or throat) - Significant liver enzyme elevation or hepatitis - Acute neuropathy worsening in rare cases

When considering Milgamma Neuro, observe the following precautions.

- Pregnancy: consult a healthcare professional before use. - Breastfeeding: use only if clearly needed and advised by a physician. - Renal impairment: monitor renal function and adjust use as recommended. - Hepatic impairment: exercise caution and consider liver function monitoring. - Concomitant medications: review all current drugs for potential interactions. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Milgamma Neuro may interact with certain medicines; monitor accordingly.

Major Interactions (Avoid): - High‑dose pyridoxine with levodopa therapy may reduce levodopa efficacy. - Concurrent use with certain chemotherapy agents may alter thiamine metabolism.

Moderate Interactions (Monitor Closely): - Antiepileptic drugs (e.g., carbamazepine) may increase pyridoxine‑related neurotoxicity. - Diuretics that cause electrolyte loss can enhance benfotiamine‑related side effects. - Oral anticoagulants: monitor INR as vitamin supplementation may affect clotting parameters.